Prosight Management »

Adicet Bio Ord shares owned by Prosight Management

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1M 250k 8.42

More positions owned by Prosight Management

Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr (GLPG)
Janux Therapeutics (JANX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Meiragtx Holdings (MGTX)
Nektar Therapeutics Com New (NKTR)
Veeva Sys Cl A Com (VEEV)
Icon SHS (ICLR)
Boston Scientific Corporation (BSX)
Concentra Group Holdings Par Common Stock (CON)
Phreesia (PHR)
Amicus Therapeutics (FOLD)
Select Medical Holdings Corporation (SEM)
Syndax Pharmaceuticals (SNDX)

View all positions for Prosight Management

Top funds holding Adicet Bio Ord

Franklin Resources
Woodline Partners
Vanguard Group
Prosight Management
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Carlyle
Acadian Asset Management
ADAR1 Capital Management
DAFNA Capital Management
Geode Capital Management
Luminus Management
Squarepoint Ops

View all funds holding Adicet Bio Ord